Benazepril
Term · Environment · MLC-T-ENV-002958
A carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. CASRN 86541-75-5
| Identifier | MLC-T-ENV-002958 |
|---|---|
| Field | Environment |
| Subject | Chemical substances |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ENV-002958",
"term": "Benazepril",
"field": "Environment",
"definition": "A carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. CASRN 86541-75-5",
"subject": "Chemical substances",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/environment/benazepril/"
}
Record 2,912 of 29,894 in Environment terminology (MLC-0121). Request the full dataset.